Diamond Biotechnology Co., Ltd (TPEX:6815)
Taiwan · Delayed Price · Currency is TWD 51.10
+1.60 (3.23%)
Mar 5, 2026, 2:18 PM CST
Diamond Biotechnology Market Cap
Diamond Biotechnology has a market cap or net worth of 2.03 billion as of March 5, 2026. Its market cap has decreased by -16.54% in one year.
Market Cap
2.03B
Enterprise Value
2.07B
Revenue
698.11M
Ranking
n/a
PE Ratio
57.58
Stock Price
51.10
Market Cap Chart
Since January 29, 2021, Diamond Biotechnology's market cap has increased from 1.68B to 2.03B, an increase of 20.84%. That is a compound annual growth rate of 3.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 2.03B | -18.89% |
| Dec 31, 2025 | 2.50B | -7.50% |
| Dec 31, 2024 | 2.71B | 12.05% |
| Dec 29, 2023 | 2.42B | 179.34% |
| Dec 30, 2022 | 864.86M | -11.33% |
| Dec 30, 2021 | 975.37M | -41.97% |
| Jan 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WeLeader Biomedical | 3.15B |
| Medimaging Integrated Solution | 3.07B |
| A Plus Biotechnology | 2.70B |
| Applied BioCode | 2.61B |
| Dynamic Medical Technologies | 2.33B |
| Wellell | 2.26B |
| OK Biotech | 1.97B |
| Taiwan Biomaterial | 1.78B |